Back to today’s briefing

Story perspectives

CRISPR-Cas9: Revolutionizing Gene Editing Amid Ethical Challenges

6/8/2025

42 10

Summary

Story summary

CRISPR-Cas9 technology is transforming the landscape of gene editing, offering hope for genetic disorders. Since its first clinical trial in 2016 and the FDA's recent approval of Casgevy® for sickle cell disease, this groundbreaking tool faces challenges like off-target effects and ethical dilemmas. Yet, relentless innovation continues to improve delivery methods and broaden its therapeutic reach.

1 of 1

Story summary

CRISPR-Cas9 technology is transforming the landscape of gene editing, offering hope for genetic disorders. Since its first clinical trial in 2016 and the FDA's recent approval of Casgevy® for sickle cell disease, this groundbreaking tool faces challenges like off-target effects and ethical dilemmas. Yet, relentless innovation continues to improve delivery methods and broaden its therapeutic reach.